相关实验视频

Updated: Jun 18, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

对临床T1三阴性乳腺癌的新辅助化疗的评估

Qian Hao1, Luyao Dai1, Lidan Chang1

  • 1The Comprehensive Breast Center, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710061, China.

Scientific reports
|August 5, 2024
PubMed
概括

新辅助化疗 (NAC) 不能改善小三阴性乳腺癌 (TNBC) 瘤患者的生存率. 辅助化疗 (AC) 在这个患者群体中显示出类似或更好的结果.

关键词:
乳腺癌特定的生存率新辅助化学疗法新辅助化学疗法总体生存率 总体生存率塞尔·塞尔 (Seer) 是一个看得见的人.这是T1三阴性乳腺癌.

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

17.5K
Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

2.2K

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...